(Q42237379)

19 October 2017

title

Deaths among people with hepatitis C in New York City, 2000-2011. (English)

1 reference

19 October 2017

4

Sarah Braunstein

1 reference

19 October 2017

Jessie Pinchoff

1

1 reference

19 October 2017

Ann Drobnik

2

1 reference

19 October 2017

Katherine Bornschlegel

3

1 reference

19 October 2017

Christine Chan

5

1 reference

19 October 2017

Jay K Varma

6

1 reference

19 October 2017

Jennifer Fuld

7

1 reference

19 October 2017

language of work or name

English

0 references

publication date

12 February 2014

1 reference

Clinical Infectious Diseases

19 October 2017

published in

1 reference

19 October 2017

volume

58

1 reference

19 October 2017

issue

8

1 reference

19 October 2017

page(s)

1047-1054

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

All-cause and incremental per patient per year cost associated with chronic hepatitis C virus and associated liver complications in the United States: a managed care perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Changing trends in hepatitis C-related mortality in the United States, 1995-2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Simeprevir increases rate of sustained virologic response among treatment-experienced patients with HCV genotype-1 infection: a phase IIb trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Treatment of genotype 1 HCV infection in the HIV coinfected patient in 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Sofosbuvir for previously untreated chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Viral hepatitis in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

All-cause and liver-related mortality in HIV positive subjects compared to the general population: differences by HCV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

What is killing people with hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Estimating the prevalence of hepatitis C infection in New York City using surveillance data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Prevalence of hepatitis C infection in New York City, 2004

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Screening for hepatitis B, C and non-alcoholic fatty liver disease: a survey of community-based physicians.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Successful integration of hepatitis C evaluation and treatment services with methadone maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Treatment of chronic hepatitis C in a state correctional facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Barriers to hepatitis C treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Barriers to the treatment of hepatitis C. Patient, provider, and system factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Clearance of hepatitis C virus after newly acquired infection in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

Baseline Characteristics and Mortality Among People in Care for Chronic Viral Hepatitis: The Chronic Hepatitis Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIU075

21 January 2018

Identifiers

DOI

10.1093/CID/CIU075

1 reference

19 October 2017

1 reference